Concepedia

Shorouk Dannoon

SD

9

Publications

333

Citations

9

H-Index

2008

Active since

Affiliations

University of California, San Francisco(Current)

Washington State University

University of Missouri

Yonsei University

Czech Academy of Sciences, Institute of Biotechnology

Shorouk Dannoon is an author at University of California, San Francisco specializing in medicine, pharmacology, and natural sciences.

ORCID

Top concepts

Publications per year

2008–2017

9

Publications

9

Radiation dose estimation using preclinical imaging with ‐metaiodobenzylguanidine (MIBG) PET

Chang‐Lae Lee, Hilla Wahnishe, George A. Sayre et al. · Medical Physics · 2010 · 72 citations · Full text

A high-affinity [18F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer

Tanushree Ganguly, Shorouk Dannoon, Mark R. Hopkins et al. · Nuclear Medicine and Biology · 2015 · 67 citations · Full text

, , +10

In vitro receptor binding assays: general methods and considerations.

Heather M. Hennkens, Shorouk Dannoon, M R Lewis et al. · PubMed · 2008 · 47 citations

, , +19

Tumor Dosimetry Using [124I]m-iodobenzylguanidine MicroPET/CT for [131I]m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft Model

Youngho Seo, W. Clay Gustafson, Shorouk Dannoon et al. · Molecular Imaging and Biology · 2012 · 46 citations · Full text

, , +9

Structure–Activity Relationship of <sup>18</sup>F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Shorouk Dannoon, Tanushree Ganguly, Hendry Cahaya et al. · Journal of Medicinal Chemistry · 2016 · 38 citations · Full text

, , +15

Rows per page

1–5 of 9